AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Balance Sheet
USA - NASDAQ:AZYO - US05479K1060 - Common Stock
1.49 USD
+0.03 (+2.05%)
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 9.30M | 16.99M | 30.39M | 39.15M | 2.48M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 15.19M | 20.64M | 6.00M | 7.17M | 7.23M | |||
| Inventories | 9.27M | 10.05M | 9.55M | 10.12M | 7.19M | |||
| Other Current Assets | 2.36M | 3.02M | 1.48M | 3.27M | 1.55M | |||
| Total Current Assets | 36.13M | 50.70M | 47.43M | 59.71M | 18.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.47M | 1.40M | 1.20M | 1.16M | 990.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 13.37M | 15.07M | 18.47M | 21.87M | 25.26M | |||
| Other Non-Current Assets | 1.37M | 1.67M | 76.00K | 80.00K | 80.00K | |||
| Total Non-Current Assets | 16.20M | 18.14M | 19.74M | 23.10M | 26.32M | |||
| TOTAL ASSETS | 52.33M | 68.84M | 67.17M | 82.81M | 44.77M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 4.76M | 6.51M | 0 | |||
| Current Portion Of LT Debt. | null | 0 | 8.06M | 6.31M | 5.92M | |||
| Accrued Expenses | 12.34M | 10.79M | 6.38M | 6.32M | 3.98M | |||
| Accounts Payable | 3.23M | 2.33M | 1.58M | 2.05M | 2.49M | |||
| Other Current Liabilities | 27.30M | 29.50M | 5.22M | 5.58M | 5.89M | |||
| Total Current Liabilities | 42.87M | 42.62M | 26.00M | 26.78M | 18.27M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 24.93M | 24.26M | 10.41M | 17.81M | 19.86M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 6.66M | 7.00M | 17.24M | 17.39M | 17.30M | |||
| Total Non-Current Liabilities | 31.59M | 31.26M | 27.65M | 35.20M | 37.16M | |||
| TOTAL LIABILITIES | 74.46M | 73.87M | 53.65M | 61.98M | 55.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -156.58M | -137.99M | -105.09M | -80.26M | -56.94M | |||
| Additional Paid In Capital | 134.44M | 132.94M | 118.60M | 101.08M | 1.82M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 16.00K | 16.00K | 13.00K | 10.00K | 44.46M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 16.25M | 16.14M | 13.56M | 10.23M | 10.23M | |||
| Tangible Book Value per Share | -2.1845 | -1.2457 | -0.3647 | -0.1017 | -7.8563 | |||
| Total Shareholders' Equity | -22.13M | -5.03M | 13.52M | 20.83M | -10.66M | |||
| TOTAL LIABILITIES AND EQUITY | 52.33M | 68.84M | 67.17M | 82.81M | 44.77M | |||
| Statistics | ||||||||
| Debt/Equity | -1.13 | -4.82 | 1.12 | 1.17 | -1.86 | |||
| Current Ratio | 0.84 | 1.19 | 1.82 | 2.23 | 1.01 | |||
| Return On Assets (ROA) | -64.87% | -47.79% | -36.97% | -30.60% | -26.67% | |||
| Return On Equity (ROE) | N/A | N/A | -183.66% | -121.65% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21